tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Viking Therapeutics Inc

VKTX
Add to Watchlist
27.280USD
+0.420+1.56%
Close 10-30 16:00（ET）
3.47BMarket Cap
LossP/E TTM
After-hours 17:40 (ET)27.070USD-0.245-0.90%

Viking Therapeutics Inc

27.280
+0.420+1.56%
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

VKTX Financials

See Viking Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
3.47B
Dividend TTM
0.00
P/E TTM
-6.57
EPS TTM
-4.15
Revenue
0.00
Net Profit
-109.96M
ROE
-70.04%
ROA
-64.04%
Viking Therapeutics Inc Earnings Date
Latest Release
Oct 28, 2026
EPS / Forecast
-1.55/-1.07
Revenue / Forecast
0.00/0.00

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
Financial Indicators
EPS
-91.98%-1.55
-88.34%-1.10
-236.48%-1.37
-334.80%-1.38
-259.46%-0.81
-190.07%-0.58
-53.98%-0.41
-29.18%-0.32
0.37%-0.22
-3.81%-0.20
-6.08%-0.26
3.60%-0.25
---0.23
---0.19
---0.25
---0.26
---0.64
----
----
----
Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Net Profit
-101.78%-183.19M
-95.27%-128.02M
-246.98%-158.32M
-345.16%-157.66M
-264.02%-90.79M
-194.66%-65.56M
-66.80%-45.63M
-43.94%-35.42M
-10.68%-24.94M
-15.73%-22.25M
-40.06%-27.36M
-25.80%-24.61M
-42.86%-22.53M
-10.29%-19.23M
-21.29%-19.53M
-58.30%-19.56M
-19.10%-15.77M
-13.33%-17.43M
-14.94%-16.10M
-12.86%-12.36M
Debt to assets ratio
--25.65%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income Statement
Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Operating profit
-89.84%-187.11M
-77.81%-132.60M
-195.89%-164.13M
-256.28%-164.74M
-169.62%-98.56M
-118.99%-74.57M
-62.79%-55.47M
-57.89%-46.24M
-34.08%-36.56M
-43.45%-34.05M
-65.91%-34.07M
-44.38%-29.29M
-68.34%-27.27M
-34.65%-23.74M
-26.42%-20.54M
-62.13%-20.28M
-20.84%-16.20M
-13.45%-17.63M
-14.18%-16.25M
-11.04%-12.51M
Net Profit
-101.78%-183.19M
-95.27%-128.02M
-246.98%-158.32M
-345.16%-157.66M
-264.02%-90.79M
-194.66%-65.56M
-66.80%-45.63M
-43.94%-35.42M
-10.68%-24.94M
-15.73%-22.25M
-40.06%-27.36M
-25.80%-24.61M
-42.86%-22.53M
-10.29%-19.23M
-21.29%-19.53M
-58.30%-19.56M
-19.10%-15.77M
-13.33%-17.43M
-14.94%-16.10M
-12.86%-12.36M
Balance Sheet
Current assets
31.72%973.00M
-37.42%517.56M
-29.77%608.21M
-21.12%715.60M
-21.13%738.70M
-12.55%827.02M
-10.38%866.02M
147.05%907.22M
145.65%936.65M
136.80%945.72M
546.52%966.34M
119.84%367.23M
130.89%381.30M
122.04%399.37M
-22.68%149.47M
-20.66%167.04M
-26.37%165.15M
-24.32%179.86M
-22.64%193.30M
-17.80%210.53M
Total current liabilities
413.66%133.90M
242.89%109.66M
443.22%106.33M
179.67%76.67M
1.49%26.07M
27.45%31.98M
-40.28%19.57M
43.26%27.41M
91.61%25.68M
86.18%25.09M
109.43%32.77M
-12.81%19.14M
-4.67%13.40M
-9.32%13.48M
38.88%15.65M
150.02%21.95M
23.85%14.06M
15.48%14.86M
-12.76%11.27M
-27.63%8.78M
Total assets
32.15%977.17M
-36.96%521.90M
-29.84%608.24M
-21.20%715.73M
-21.16%739.41M
-12.57%827.85M
-10.39%866.99M
146.50%908.32M
145.10%937.89M
136.30%946.84M
541.19%967.52M
118.65%368.49M
129.58%382.66M
120.76%400.69M
-22.63%150.90M
-20.00%168.53M
-25.75%166.68M
-23.69%181.51M
-22.03%195.03M
-17.87%210.66M
Total liabilities
1372.68%388.57M
250.67%113.58M
429.64%106.33M
173.39%76.67M
-0.21%26.39M
25.26%32.39M
-40.30%20.07M
39.72%28.04M
83.32%26.44M
77.38%25.86M
99.80%33.63M
-13.51%20.07M
-6.33%14.42M
-10.44%14.58M
31.92%16.83M
164.38%23.21M
35.63%15.40M
26.47%16.28M
-1.22%12.76M
-27.80%8.78M
Total equity
-17.45%588.60M
-48.67%408.32M
-40.74%501.92M
-27.40%639.06M
-21.77%713.03M
-13.63%795.46M
-9.31%846.92M
152.65%880.28M
147.51%911.45M
138.52%920.98M
596.60%933.89M
139.76%348.42M
143.41%368.24M
133.68%386.12M
-26.45%134.06M
-28.02%145.32M
-29.01%151.28M
-26.56%165.23M
-23.17%182.27M
-17.38%201.88M
Cash Flow Statement
Net operating income
-47.01%-138.19M
-165.98%-125.17M
-117.80%-113.98M
-173.53%-85.29M
-328.03%-94.00M
-65.05%-47.06M
-753.13%-52.33M
-76.76%-31.18M
-11.72%-21.96M
-149.35%-28.51M
75.11%-6.13M
-61.45%-17.64M
-45.63%-19.66M
14.93%-11.44M
-134.03%-24.64M
11.53%-10.93M
-23.55%-13.50M
-0.06%-13.44M
3.18%-10.53M
-125.12%-12.35M
Net investment
-42.18%92.52M
157.45%109.43M
-14.32%54.19M
1048.42%75.61M
517.83%160.03M
133.72%42.51M
113.76%63.24M
-81.57%6.58M
306.65%25.90M
38.35%-126.06M
-21018.65%-459.79M
392.19%35.73M
-146.61%-12.53M
-1177.36%-204.48M
35.76%2.20M
-73.51%7.26M
97.50%26.89M
433.15%18.98M
124.43%1.62M
-9.45%27.41M
Net financing
124389.79%597.55M
4552.07%23.59M
3360.46%12.08M
7410.30%75.10M
-80.97%480.00K
-82.55%507.00K
-99.94%349.00K
431.91%1.00M
3508.11%2.52M
-98.91%2.91M
14384.63%606.04M
-98.25%188.00K
-840.00%-74.00K
16897.36%267.08M
183.58%4.18M
22770.21%10.75M
103.91%10.00K
-183.77%-1.59M
-196.44%-5.01M
-89.87%47.00K

FAQs

What are the current assets of Viking Therapeutics Inc?

According to Viking Therapeutics Inc's FY2025 earnings report, its current assets were 715.60M, with a year-on-year change of -21.12.

What are the total assets of Viking Therapeutics Inc?

According to Viking Therapeutics Inc's FY2025 earnings report, its total assets of Viking Therapeutics Inc were 715.73M, with a year-on-year change of -21.20.

What are the total liabilities of Viking Therapeutics Inc?

According to Viking Therapeutics Inc's FY2025 earnings report, its total liabilities of Viking Therapeutics Inc were 76.67M, with a year-on-year change of 173.39.

What is the total equity of Viking Therapeutics Inc?

According to Viking Therapeutics Inc's FY2025 earnings report, its total equity of Viking Therapeutics Inc was 639.06M, with a year-on-year change of -27.40.

What is the net operating income of Viking Therapeutics Inc?

According to Viking Therapeutics Inc's FY2025 earnings report, its net operating income of Viking Therapeutics Inc was -393.34M, with a year-on-year change of -160.63.

What is the net investment of Viking Therapeutics Inc?

According to Viking Therapeutics Inc's FY2025 earnings report, its net investment of Viking Therapeutics Inc was 341.39M, with a year-on-year change of 161.69.

What is the net financing of Viking Therapeutics Inc?

According to Viking Therapeutics Inc's FY2025 earnings report, its net financing of Viking Therapeutics Inc was 76.44M, with a year-on-year change of -87.52.

What is the Earnings Per Share (EPS) of Viking Therapeutics Inc?

According to Viking Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.19, with a year-on-year change of -216.52.

What is the net income of Viking Therapeutics Inc?

According to Viking Therapeutics Inc's FY2025 earnings report, its net income was -359.64M, with a year-on-year change of -227.05.

What is the Return on Equity (ROE) of Viking Therapeutics Inc?

According to Viking Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -47.34, with a year-on-year change of -164.49.

What is the Return on Assets (ROA) of Viking Therapeutics Inc?

According to Viking Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -44.29, with a year-on-year change of -157.13.

What is the operating profit of Viking Therapeutics Inc?

According to Viking Therapeutics Inc's FY2025 earnings report, its operating profit was -393.34M, with a year-on-year change of -160.63.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy